Trial Profile
Non-invasive determination of central aortic blood pressure in hypertensive patients treated with controlled-release carvedilol or atenolol.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2023
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Atenolol
- Indications Essential hypertension
- Focus Therapeutic Use
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 21 May 2008 New trial record.